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Background: We investigated bone marrow (BM) from 35 subjects enrolled in the NHLBI Cardiovascular Cell Therapy Research Network (CCTRN). 
Recruitment into the TIME and LateTIME trials included patients who suffered an acute myocardial infarction (AMI) and FOCUS included patients 
who had remote MI. The patients in all trials had severe left ventricular dysfunction. Eligible patients underwent BM harvest of cells for CD34+ cell 
delivery early after acute AMI (3 or 7 days for TIME, N=6 and 4, respectively) or late (14-21 days Late-TIME, N=10), or FOCUS (N=4) which included 
patients who were greater than 30 days after an ACS event. We also analyzed healthy subjects as controls (N=3).
Methods/Results: We analyzed bioavailable nitric oxide (NO) utilizing a fluorescent technique. CD34+ cells isolated from BM of patients 3-7 
days post AMI had significantly less (p less than 0.05) bioavailable NO as compared to cells isolated from either patients 14-21 days or from 
patients >30 days post AMI. When compared to normal controls, there was no significant difference in bioavailable NO in cells isolated from 
patients either 14-21 days or from patietns >30 days. Analysis of CD34+ cells isolated from the BM of patients at various time points after an AMI 
demonstrated no differences in migration characteristics.
Conclusions: Our preliminary results suggest that there is a significantly reduction in bioavailable NO in CD34+ cells of the BM acutely after an 
MI. Future studies will focus on determining whether the acute decrease in bioavailable NO is due to an acute increase in reactive oxygen species or 
due to a decrease in endothelial nitric oxide synthase. In addition, we await patient outcomes to determine the optimal timing with regard to AMI for 
collection of cells to attain the maximum benefit of cell-based cardiac therapies.
